Literature DB >> 6120642

Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic.

H Heider, B Adamczyk, H W Presber, C Schroeder, R Feldblum, M K Indulen.   

Abstract

The sensitivities to amantadine and rimantadine of influenza A virus epidemic strains were assayed by the haem-adsorption reduction test in mouse Ehrlich ascites cells in comparison with prototype strains and a rimantadine-resistant mutant. Besides a majority of sensitive strains, two relatively resistant epidemic strains were identified. The possible origin of resistant strains and their importance for medical practice are discussed.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6120642

Source DB:  PubMed          Journal:  Acta Virol        ISSN： 0001-723X            Impact factor:   1.162


  10 in total

1.  Amantadine for influenza A.

Authors:  K G Nicholson; M J Wiselka
Journal:  BMJ       Date:  1991-02-23

2.  Oral ribavirin treatment of influenza A and B.

Authors:  D S Stein; C M Creticos; G G Jackson; J M Bernstein; F G Hayden; G M Schiff; D I Bernstein
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

3.  Relation between drug resistance and antigenicity among norakin-resistant mutants of influenza A (fowl plague) virus.

Authors:  A I Klimov; S G Markushin; S Prösch; V P Ginzburg; H Heider; A M Heider; C Schröeder; R G Webster
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  Current status of amantadine and rimantadine as anti-influenza-A agents: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

5.  The influence of Norakin on the reproduction of influenza A and B viruses.

Authors:  H Heider; S Markushin; C Schroeder; Y Ghendon
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

Review 6.  Drug resistance in influenza A virus: the epidemiology and management.

Authors:  Mazhar Hussain; Henry D Galvin; Tatt Y Haw; Ashley N Nutsford; Matloob Husain
Journal:  Infect Drug Resist       Date:  2017-04-20       Impact factor: 4.003

Review 7.  Antiviral chemotherapy and prophylaxis of viral respiratory disease.

Authors:  S J Sperber; F G Hayden
Journal:  Clin Lab Med       Date:  1987-12       Impact factor: 1.935

8.  Inhibitory effects of aprotinin on influenza A and B viruses in vitro and in vivo.

Authors:  Eun-Jung Song; Erica Españo; Sang-Mu Shim; Jeong-Hyun Nam; Jiyeon Kim; Kiho Lee; Song-Kyu Park; Chong-Kil Lee; Jeong-Ki Kim
Journal:  Sci Rep       Date:  2021-05-03       Impact factor: 4.379

9.  Chapter 7 Orthomyxovirus infections.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29

10.  Chapter 3 Antiviral drugs: general considerations.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.